NeuMoDx coronavirus test gets emergency authorization

2019 05 02 23 38 2538 Check Mark 400

NeuMoDx Molecular's assay for SARS-CoV-2 has received an emergency use authorization (EUA) from the U.S. Food and Drug Administration.

The reverse transcription polymerase chain reaction (RT-PCR) test was designed for use on the company's high-throughput NeuMoDx 288 and 96 molecular systems in CLIA-certified hospitals and labs that perform high-complexity testing. Results are available in as little as 80 minutes, according to the company.

NeuMoDx also noted that reagents and consumables associated with the SARS-CoV-2 test are ready to use and do not require refrigeration.

Page 1 of 23
Next Page